A. “Epidermal growth factor receptor is a preferred target for treating Amyloid-{beta}-induced memory loss,” by Lei Wang, Hsueh-Cheng Chiang, Wenjuan Wu, Bin Liang, Zuolei Xie, Xinsheng Yao, Weiwei Ma, Shuwen Du, and Yi Zhong (Vol. 109, No. 49, October 9, 2012, p. 16743-16748).
www.pnas.org/content/109/41/16743.abstract
B. “Dicyanovinylnaphthalenes for neuroimaging of amyloids and relationships of electronic structures and geometries to binding affinities,” by Andrej Petric, Scott A. Johnson, Hung V. Pham, Ying Li, Simon Ceh, Amalija Golobic, Eric D. Agdeppa, Gerald Timbol, Jie Liu, Gyochang Keum, Nagichettiar Satyamurthy, Vladimir Kepe, Kendall N. Houk, and Jorge R. Barrio (Vol. 109, No. 49, October 9, 2012, p. 16492-16497).
